Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
Recruiting · NCT06315231 · Registry updated 2025-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients | Post-stroke Cognitive Impairment | Recruiting | Phase 2 | 2025-09-03 | NCT06315231 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Simcere Pharmaceutical Co., Ltd | 5 |
21 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.